【Announcement Selection】Rock Co., Ltd.: The company and Haiyin Holdings only have liquor sales business, and Insai Group: It is expected that hot issues such as AIGC and short dramas will have little impact on the company's performance in 2023

Huayang Group: plans to invest 1 billion yuan to build a "automotive lightweight precision die-casting parts project" Huayang Group (002906) announced on the evening of December 18 that the company intends to sign the "Changxing Economic and Technological Development Zone Investment Agreement" with the Changxing Economic and Technological Development Zone Management Committee, and the name of the investment project is "automotive lightweight precision die-casting parts project", and the project fixed asset investment (including land) The total amount is expected to be about 1 billion yuan, and a subsidiary will be invested and set up in Changxing Economic and Technological Development Zone to be responsible for the investment, construction and operation of the project, with a registered capital of about 200 million yuan. Canrui Technology: Plans to repurchase shares with 20 million yuan to 40 million yuan Canrui Technology (688061) announced on the evening of December 18 that the company intends to repurchase the company's shares in a centralized bidding transaction, and the total amount of shares to be repurchased is not less than 20 million yuan, not more than 40 million yuan, and the repurchase price is not more than 50 yuan per share. Huayang Group: plans to invest 1 billion yuan to build the "automotive lightweight precision die-casting parts project" Huayang Group (002906) announced on the evening of December 18 that the company intends to sign the "Changxing Economic and Technological Development Zone Investment Agreement" with the Changxing Economic and Technological Development Zone Management Committee, the name of the investment project is "automotive lightweight precision die-casting parts project", the total investment in fixed assets (including land) of the project is expected to be about 1 billion yuan, and the establishment of a subsidiary in the Changxing Economic and Technological Development Zone is responsible for project investment, construction, The registered capital of the project company is about 200 million yuan. Zhongzhi shares: the company's restructuring matters on December 25 at the meeting, Zhongzhi shares (600038) announced on the evening of December 18 that the company intends to issue shares to purchase 100% of the shares of Changhe Aircraft Industry (Group) Co., Ltd. and Harbin Aircraft Industry Group Co., Ltd. and raise matching funds. The M&A and Reorganization Review Committee of the Shanghai Stock Exchange is scheduled to hold the 10th review meeting of the M&A and Reorganization Review Committee in 2023 on December 25 to review the company's application for this restructuring. ST Ruide: The subsidiary plans to invest 182 million yuan in the construction of the second phase of the computing power cluster ST Ruide (600666) announced on the evening of December 18 that according to the company's business development needs, the company's wholly-owned subsidiary invested in the construction of the second phase of the computing power cluster to provide customers with computing power leasing services, with a project investment of about 182 million yuan, and the funds are mainly used for the purchase of servers, switches, network cards and supporting software and hardware equipment. As of the disclosure date of the announcement, all the servers and related software and hardware required for the construction of the project have arrived, and some equipment has been networked and tested. The company's wholly-owned subsidiary will provide customers with computing power leasing services based on the construction and deployment of the second phase of the computing power cluster. Rock shares: The company and Haiyin Holdings only have alcohol sales business No other business dealingsRock shares (600696) on the evening of December 18 disclosed the announcement of stock trading changes, recently, the company's related party Haiyin Holdings Co., Ltd. stock price has fluctuated greatly. Up to now, the company and Haiyin Holdings and its subsidiaries only have liquor sales business, with a transaction amount of 48,800 yuan, except for the above business, the company has no other business dealings with Haiyin Holdings. In addition, the company intends to repurchase all the shares for employee stock ownership plans or equity incentives, and the total amount of funds to be repurchased shall not be less than 60 million yuan and not more than 100 million yuan, and the repurchase price shall not exceed 32.60 yuan per share. Angel Yeast: Plans to set up a joint venture in Algeria to expand business Angel Yeast (600298) announced on the evening of December 18 that in order to further consolidate and enhance the company's market leading advantage in Africa and strengthen its strategic layout, the company's subsidiary Angel Yeast (Egypt) Co., Ltd. (hereinafter referred to as "Egypt Company") intends to set up a joint venture company with Bosaba Company in Algeria to carry out yeast and food ingredients business. The registered capital of the joint venture is about 1.4 million US dollars, of which 938,000 US dollars is invested by the Egyptian company. Unnamed Pharmaceutical: The subsidiary intends to be selected by the Jiangxi Interprovincial Interprovincial Alliance for the centralized procurement of Unnamed Pharmaceutical (002581) announced on the evening of December 18 that the holding subsidiary Tianjin Weiming Biopharmaceutical Co., Ltd. (hereinafter referred to as "Tianjin Weiming") participated in the bidding activities of the centralized procurement of the Jiangxi Interprovincial Interprovincial Alliance, according to the "Notice on the Announcement of the Proposed Winning Results of the Interprovincial Alliance of Interferon Interprovincial Alliance" issued by the Jiangxi Provincial Medical Security Bureau It shows that Tianjin Weiming interferon α2b spray plans to win the bid for this centralized procurement. The operating income of human interferon α2b spray in 2022 will be about 229 million yuan, accounting for about 64.27% of the company's total operating income in 2022. Insai Group: It is expected that AIGC, short dramas, Yuanmengxing and other hot issues will have a small impact on the company's 2023 annual performance, and Insai Group (300781) announced on the evening of December 18 that recently, AIGC, short dramas, Yuanmengxing and other hot spots have received widespread attention from investors. The company's recently released InsightGPT is only an internal beta version, which has not yet been commercialized and has not generated revenue, and will face related risks such as technology iteration and market competition in the follow-up technology research and development, application and operation process, and there is great uncertainty about whether it can achieve the expected results in the future The above events are expected to have a small impact on the company's 2023 annual results. Inner Mongolia Xinhua: "One Brain" project is the company's internal management system Inner Mongolia Xinhua (603230) announced on the evening of December 18 that the company's "One Brain" project is a sub-project of the fundraising project "Smart Operation Management System Upgrade Project", with an investment of less than 100,000 yuan. This project is the company's internal management system, which cannot directly bring profits, does not involve the concept of AI, and the company does not belong to the concept of digital elements. Regarding the public opinion of short videos, the company only opened an account on the short video platform for publishing news such as product promotion and publicity, but did not involve the short video business. Qixin Group: It plans to repurchase shares for 30 million yuan to 60 million yuan, and Qixin Group (002301) announced on the evening of December 18 that it intends to use its own funds to repurchase shares for 30 million yuan to 60 million yuan through centralized bidding transactions for the implementation of equity incentives or employee stock ownership plans. The repurchase price is not more than 10.50 yuan per share. Jinyu Medical: It is planned to repurchase shares with 50 million yuan to 100 million yuanJinyu Medical (603882) announced on the evening of December 18 that the company intends to repurchase the company's shares through centralized bidding transactions for the implementation of equity incentives. The total amount of repurchase funds shall not be less than 50 million yuan and not more than 100 million yuan, and the repurchase price shall not exceed 80 yuan per share. On the evening 300377 of December 18, Tang Qiu, one of the actual controllers and chairman of the board of directors, was placed in custody by the Liaoning Yingkou Discipline Inspection Commission, and Tang Qiu, one of the actual controllers and chairman of the company, was placed in custody by the Liaoning Yingkou Discipline Inspection Commission to cooperate and assist in the investigation of relevant matters. The company's senior management team has made proper arrangements for related matters, and the company's production and operation are currently proceeding normally. Editor-in-charge: Zhang Qianyao Proofreader: Liao Shengchao